These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 2762920

  • 1. [Disorders of fatty acid composition and the processes of lipid peroxidation in chronic ischemic heart disease].
    Kalmykova VI, Zakharova EV.
    Sov Med; 1989; (4):5-8. PubMed ID: 2762920
    [Abstract] [Full Text] [Related]

  • 2. Protective effects of curcumin and photo-irradiated curcumin on circulatory lipids and lipid peroxidation products in alcohol and polyunsaturated fatty acid-induced toxicity.
    Rukkumani R, Sri Balasubashini M, Menon VP.
    Phytother Res; 2003 Sep; 17(8):925-9. PubMed ID: 13680826
    [Abstract] [Full Text] [Related]

  • 3. [Effect of n-3 polyunsaturated fatty acids on plasma lipid, LDL lipoperoxidation, homocysteine and inflammation indicators in diabetic dyslipidemia treated with statin + fibrate combination].
    Zeman M, Zák A, Vecka M, Tvrzická E, Písaríková A, Stanková B.
    Cas Lek Cesk; 2005 Sep; 144(11):737-41. PubMed ID: 16335699
    [Abstract] [Full Text] [Related]

  • 4. Effects of Scandinavian caviar paste enriched with a stable fish oil on plasma phospholipid fatty acids and lipid peroxidation.
    Engström K, Wallin R, Saldeen T.
    Eur J Clin Nutr; 2003 Sep; 57(9):1052-9. PubMed ID: 12947422
    [Abstract] [Full Text] [Related]

  • 5. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
    Derosa G, Cicero AE, Bertone G, Piccinni MN, Ciccarelli L, Roggeri DE.
    Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
    [Abstract] [Full Text] [Related]

  • 6. [Lipid peroxidation upon the use of omega-3 polyunsaturated fatty acids in the treatment of hypertension and ischemic heart disease].
    Karagodina ZV, Korf II, L'vovich NA, Abbakumov AS, Pogozheva AV, Levachev MM.
    Vopr Med Khim; 1992 Oct; 38(3):20-2. PubMed ID: 1413641
    [Abstract] [Full Text] [Related]

  • 7. Comparison of changes in erythrocyte and platelet phospholipid and fatty acid composition and protein oxidation in chronic obstructive pulmonary disease and asthma.
    De Castro J, Hernández-Hernández A, Rodríguez MC, Sardina JL, Llanillo M, Sánchez-Yagüe J.
    Platelets; 2007 Feb; 18(1):43-51. PubMed ID: 17365853
    [Abstract] [Full Text] [Related]

  • 8. [Lipid peroxidation in patients with ischemic heart disease, hyperlipidemia and/or hypertension while polyunsaturated omega-3 fatty acids of plant and animal origin were in their diet].
    Pogozheva AV, Rozanova IA, Sorokovoi KV, Karagodina ZV, Levachev MM.
    Vopr Pitan; 1997 Feb; (4):32-5. PubMed ID: 9412077
    [Abstract] [Full Text] [Related]

  • 9. Changes in serum lipoprotein lipids and their fatty acid compositions and lipid peroxidation in growing rats fed soybean protein versus casein with or without cholesterol.
    Madani S, Frenoux JM, Prost J, Belleville J.
    Nutrition; 2004 Jun; 20(6):554-63. PubMed ID: 15165619
    [Abstract] [Full Text] [Related]

  • 10. Lipid peroxidation in relation to vitamin C and vitamin E levels.
    Krajcovicová-Kudlácková M, Pauková V, Baceková M, Dusinská M.
    Cent Eur J Public Health; 2004 Mar; 12(1):46-8. PubMed ID: 15068210
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Fatty acid and lipid peroxidation in human atherosclerosis].
    Loeper J, Goy J, Emerit J, Rozensztajn L, Jeny C, Bedu O.
    Sem Hop; 1983 Jun 02; 59(22):1657-60. PubMed ID: 6308785
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Changes in lipid metabolism and antioxidant defense status in spontaneously hypertensive rats and Wistar rats fed a diet enriched with fructose and saturated fatty acids.
    Girard A, Madani S, El Boustani ES, Belleville J, Prost J.
    Nutrition; 2005 Feb 02; 21(2):240-8. PubMed ID: 15723754
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Peroxisome proliferator-activated receptor alpha agonist, clofibrate, has profound influence on myocardial fatty acid composition.
    Tian Q, Grzemski FA, Panagiotopoulos S, Ahokas JT.
    Chem Biol Interact; 2006 Apr 15; 160(3):241-51. PubMed ID: 16540100
    [Abstract] [Full Text] [Related]

  • 19. [Effect of long-term cardiac training on lipids concentration in patients with chronic heart ischemic disease treated with simvastatin].
    Kałka D, Sobieszczańska M, Kopka L, Marciniak W, Zawadzka-Bartczak E, Bak A, Popielewicz-Kautz A, Korzeniowska J, Janczak J, Adamus J.
    Pol Merkur Lekarski; 2007 Feb 15; 22(128):101-6. PubMed ID: 17598652
    [Abstract] [Full Text] [Related]

  • 20. [Effect of psychopathological disorders in patients with unstable stenocardia on serum lipids and the indicators of lipid peroxidation].
    Govorin AV, Neverov IV, Govorin NV, Gerasimovich AI, Chaban SN, Molchanov SN, Filev AP.
    Ross Med Zh; 1992 Feb 15; (4):9-11. PubMed ID: 1521030
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.